Company fact sheet

Rottapharm | Madaus an R&D-driven, multinational company with Italian roots

Business activities
Pharmaceutical multinational company based in Monza (Italy) focused on the research, innovation, development and global distribution of new, mainly natural-pharmaceutical products, para-pharmaceutical and nutraceutical products.

Headquarters
Monza (Italy) - Via Valosa di Sopra, 9

Research Center
Rotta Research Laboratorium, the R&D division of Rottapharm | Madaus, is based in Monza, near Milan, ltaly

R&D activities | research fields
To date the intense research activity has generated over 4000 molecular hits, about 300 patents and 19 new drugs.
Several new Chemical entities are at an advanced stage of research. R&D activities are currently engaged in different therapeutic areas:

• gastroenterology
• bronchopneumology
• psychiatry
• rheumatology
• urology
• gynaecology
• oncology

Rottapharm | Madaus R&D activities have recently expanded in the personal care and nutraceutical segment.

Facilities
Rottapharm | Madaus has manufacturing sites in:

• Confienza (Italia)
• Dublino (Irlanda)
• Troisdorf (Germania)
  
• Barcelona, (Spagna) Euromed
• Goa, India 

Leading brands
Ananase, Armolipid, Epinitril, Estromineral, Saugella, Babygella,Agiolax

International presence
85 countries worldwide

Employees (2011)
More than 2000 

Net revenue (2010)
600 million Euros

Social Responsibility
Besides the scientific research activities and the development of innovative products to improve people live, Rottapharm | Madaus is involved in different, important social projects, local, national and worldwide.